Join us at the Society for Clinical Research Sites (SCRS)
Join us at the Society for Clinical Research Sites (SCRS) Summit in Amsterdam, NL, 2-3 March! ☕🥐 As the official Opening Breakfast Sponsor, we invite you to join us for morning coffee and conversation to kick off your day at the Summit. It’s a perfect opportunity to connect with peers, exchange insights, and discuss the […]
Inspection Readiness: Your Key to Confident FDA Inspections
📚 FDA inspections can feel intense for early phase units — but they don’t have to be. When readiness becomes part of daily operations, an inspection turns from a pressure point into a moment to show the strength of your processes, your people, and your quality culture. 📒 At hashtag#Biokinetica, we’ve lived this in practice: […]
Case study: Delivering Speed & QualityPhase 1 Biosimilar Study
Speed and data quality don’t have to compete in early-phase biosimilar programs — but they do require disciplined planning, coordinated start-up, and consistent operational oversight. In this Phase 1 study, a structured start-up model and focused recruitment strategy supported predictable timelines and stable study conduct from activation through completion. Operational focus areas:– Rapid, coordinated start-up– […]
World Cancer Day
World Cancer Day reminds us that cancer is more than a statistic — behind every diagnosis is a unique human story. Together, we are UnitedByUnique, working toward more people-centred care and better outcomes for patients worldwide. With nearly 20 million new cancer cases in 2022 — and projections reaching ~35 million by 2050 *— accelerating […]
Early-phase studies are ramping up in 2026
🔬 Early-phase studies are ramping up in 2026, and Biokinetica is fully prepared to support them. Early-phase studies are critical “make-or-break” moments in drug development, therefore require more than a site — they demand a partner with proven expertise, robust infrastructure, and strong recruitment capabilities. Our team provides operational experience, dedicated project management, and continuous […]
Unit Designed for Precision and Speed
Designed to support complex early-phase studies with speed, safety, and precision, our 50-bed, state-of-the-art Phase I unit offers a dedicated screening unit, 24/7 medical monitoring, a 5-bed in-house ECU with direct access to a cardiac ECU, and full on-site support through our pharmacy and sample processing laboratory. 🌟 The unit is fully certified for QTc […]
2025 Highlights
⬅️ Looking back on 2025, we’re grateful for a year shaped by shared development across our early‑phase research work. Together, we strengthened our scientific offering, improved data precision, and expanded the expertise needed to support more complex studies. We also deepened international collaborations, built a more connected framework for future programs, and successfully completed an […]
Cervical Cancer Awareness Month
🎗January marks Cervical Cancer Awareness Month — a time to highlight prevention, early detection, and the ongoing need for innovation in women’s health. Raising awareness, encouraging regular screening, and supporting access to new therapeutic options remain essential steps toward reducing its global impact. As a European Early Phase Clinical Research Unit with strong expertise in […]
Biosimilar Market Momentum
In late 2025, the biosimilars market picked up real momentum. New approvals in Europe, strategic product launches, and major partnerships in the U.S. show just how fast this space is growing — as highlighted in a recent article by The Center for Biosimilars. At Biokinetica, we see this progress as a strong reminder of how […]
Joyful Holiday Season
✨🎄The holiday season is the perfect time to reflect on the past year. A heartfelt thank you to our clients for your trust and successful collaboration throughout 2025. To our patients and volunteers — we truly appreciate your participation and support. Wishing you all a joyful HolidaySeason, full of love and happiness, and a bright, […]
